Granules Jeedimetla facility located at Hyderabad, Telangana, India has successfully completed the US FDA’s surveillance inspection with zero observations, the company announced through an exchange filing. The inspection was completed between June 19 and June 23.
Jeedimetla facility manufactures Active Pharmaceutical Ingredients (API) and Pharmaceutical Formulation Intermediates (PFIs).
Granules shares
The shares of Granules on Friday closed at Rs 286.95, down by 0.35 per cent.
Mumbai: Krsnaa Diagnostics Temporarily Suspends BMC Pathology Services Over Pending Dues Worth Over ₹10 Cr
PKL 2024: Check Out The Format, Teams And Where To Watch The Tournament On TV & Online
Mumbai: 23-Yr-Old Dies By Suicide In Hostel Room In Chembur
Mumbai: CBI Opposes Gangster Abu Salem's Plea Seeking Information On His Release Date
